The Lowell P. Weicker, Jr.
Clinical Research Center (CRC) Seminar Series
On Methods in Clinical Research
Sponsored by the University of Connecticut School of Medicine
Office of Community and Continuing Medical Education and the Clinical Research Center
“From Stem Cells to Clinical Trials: The Quest for a Cure for Huntington’s Disease”
Carolyn Drazinic, M.D., Ph.D.
Assistant Professor, Department of Psychiatry and Department of Genetics and Developmental Biology
University of Connecticut Health Center
Farmington, CT
Date: Tuesday, January 14, 2014
Time: 12:00 Noon – 1:00 P.M.
Location: Low Learning Center – UCHC, Farmington, CT
WEB CAST: http://mediasite.uchc.edu/mediasite41/Catalog/Full/8ae6f507dcf6496291465484f6db849921(Note: No CME’s given for Web Cast viewing)
Light lunch and beverage provided
Target Audience: Faculty, staff, residents, and students interested in clinical research.
Objectives: Participants will be able to: a. Become familiar with the full range of services available at the UConn Huntington’s Disease (HD) Program, including neuropsychiatric treatment, psychological testing, genetic counseling, disability assistance, and clinical trials like CREST-E and Reach2HD; b. Learn the basic molecular, genetic, and cellular pathophysiology of HD; c. Discuss the barriers to care experienced by patients with a known genetic disorder like HD, including discrimination in access to medical care, health/life/disability insurances, and employment opportunities; d. Appreciate how stem cell technology can be used to develop a better understanding of the cellular pathology of HD and discover new treatments for neuropsychiatric disorders.
Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Connecticut School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Policy: All faculty members participating in CME activities sponsored by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.
The Activity Director, planning committee members and Dr. Drazinic do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. Dr. Drazinic will be discussing the off-label use of PBT2 and creatine clinical trials, mood stabilizers, and antioxidants to treat symptoms/slow disease progression.
This CME activity has no commercial support associated with it. Food and refreshments provided by the CRC.
For more information, contact: Lisa Godin at Godin@nso.uchc.edu